Curcumol
CAS No. 4871-97-0
Curcumol( Curcumol )
Catalog No. M18633 CAS No. 4871-97-0
Curcumol, a pure monomer isolated extracted from Rhizoma Curcumaeis, has antitumor activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | Get Quote |
|
| 10MG | 55 | Get Quote |
|
| 25MG | 87 | Get Quote |
|
| 50MG | 133 | Get Quote |
|
| 100MG | 196 | Get Quote |
|
| 200MG | 294 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCurcumol
-
NoteResearch use only, not for human use.
-
Brief DescriptionCurcumol, a pure monomer isolated extracted from Rhizoma Curcumaeis, has antitumor activities.
-
DescriptionCurcumol, isolated from the traditional medical plant Rhizoma Curcumae, is the bioactive component of Zedoary oil, whose potential anti-tumor effect has attracted considerable attention in recent years. Curcumol inhibits the proliferation of gastric adenocarcinoma MGC-803 cells via downregulation of IDH1. Curcumol triggers apoptosis of p53 mutant triple-negative human breast cancer MDA-MB 231 cells via activation of p73 and PUMA. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway. Curcumol Promotes Vascular Endothelial Growth Factor (VEGF)-Mediated Diabetic Wound Healing in Streptozotocin-Induced Hyperglycemic Rats.
-
In Vitro——
-
In Vivo——
-
SynonymsCurcumol
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorJAK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number4871-97-0
-
Formula Weight236.35
-
Molecular FormulaC15H24O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL 423.10 mM; H2O : < 0.1 mg/mL
-
SMILESC1C[C@@H]([C@@]23C[C@H]([C@@](CC(=C)[C@H]12)(O3)O)C(C)C)C
-
Chemical Name(3S,3aS,5S,6R,8aS)-Octahydro-3-methyl-8-methylene-5-(1-methylethyl)-6H-3a,6-epoxyazulen-6-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang W, et al. Med Oncol, 2011, 28(1), 307-314.
molnova catalog
related products
-
TNIK-IN-5
TNIK-IN-5 is an inhibitor of TNIK and can be used in studies about the treatment of anti-tumor and anti-inflammatory diseases.
-
TNKS-2-IN-2
TNKS-2-IN-2 is a novel and potent TNKS2 selective inhibitor (IC50: 22 nM) with potential anti-tumour activity for studying colon cancer, lung cancer, and breast cancer.
-
IWP-2
IWP-2 is an inhibitor of Wnt processing and secretion with IC50 of 27 nM in a cell-free assay, selective blockage of Porcn-mediated Wnt palmitoylation, does not affect Wnt/β-catenin in general and displays no effect against Wnt-stimulated cellular responses.
Cart
sales@molnova.com